BioCentury
ARTICLE | Clinical News

MethylGene, MGI preclinical data

May 23, 2005 7:00 AM UTC

MG98 sensitized and overcame the resistance of human renal cancer cells to the effects of interferon (IFN) alpha. The DNA methyltransferase 1 inhibitor enhanced the effect of IFN alpha by demethylati...